{"transactions":[{"id":729455,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T21:45:22.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":263884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":263884,"derivative":{"exercise_price":0.8297,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":263884},"source":{"system":"sec-edgar","filing":"0001193125-26-279834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279834/ownership.xml","form_type":"4"}},{"id":729454,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:45:22.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":99116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":344456,"source":{"system":"sec-edgar","filing":"0001193125-26-279834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279834/ownership.xml","form_type":"4"}},{"id":874915,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T00:31:32.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":51282,"price":1.17,"value":59999.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% on the last day of the last month of each fiscal quarter of 2026, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $60,000 in cash compensation for certain services as a board member."}],"balance_after":245340,"source":{"system":"sec-edgar","filing":"0001193125-26-086154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526086154/ownership.xml","form_type":"4"}},{"id":1102909,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-06-24T22:58:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":188490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":188490,"derivative":{"exercise_price":1.05,"expiration_date":"2035-06-20","underlying":"Common Stock","underlying_shares":188490},"source":{"system":"sec-edgar","filing":"0000950170-25-089653","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089653/ownership.xml","form_type":"4"}},{"id":1102908,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:58:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":94592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":194058,"source":{"system":"sec-edgar","filing":"0000950170-25-089653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025089653/ownership.xml","form_type":"4"}},{"id":1230538,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-04T22:52:41.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":56338,"price":1.065,"value":59999.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest as to 25% on the last day of the last month of each fiscal quarter of 2025, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $60,000 in cash compensation for certain services as a board member."}],"balance_after":99466,"source":{"system":"sec-edgar","filing":"0000950170-25-032559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025032559/ownership.xml","form_type":"4"}},{"id":1463661,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-07-02T21:16:50.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":108319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option becomes exercisable in twelve equal monthly installments beginning on July 28, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":108319,"derivative":{"exercise_price":1.77,"expiration_date":"2034-06-28","underlying":"Common Stock","underlying_shares":108319},"source":{"system":"sec-edgar","filing":"0000950170-24-080717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024080717/ownership.xml","form_type":"4"}},{"id":1463660,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T21:16:50.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":43128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in full on the earlier to occur of June 28, 2025 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person declined and forfeited the 79,412 RSUs previously granted to the Reporting Person on January 5, 2024 in connection with the transactions contemplated by the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc., Martis Merger Sub, Inc. and SomaLogic, Inc."}],"balance_after":43128,"source":{"system":"sec-edgar","filing":"0000950170-24-080717","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017024080717/ownership.xml","form_type":"4"}},{"id":1682303,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-10T02:18:06.000Z","date":"2024-01-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":185400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the \"Company\") entered into the Agreement and Plan of Merger (the \"Merger Agreement\"), with Standard BioTools Inc., a Delaware corporation (\"Parent\"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the \"Merger Sub\"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the \"Merger\"); and"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) each option to purchase Company Common Stock (a \"Company Option\"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 shares (the \"Exchange Ratio\") of the Parent's common stock, par value $0.001 (the \"Parent Common Stock\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4th of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":185400},"source":{"system":"sec-edgar","filing":"0001209191-24-001312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574633/000120919124001312/doc4.xml","form_type":"4"}},{"id":1683001,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-09T23:05:19.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":205794,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc. (the \"Company\"), Martis Merger Sub, Inc. and SomaLogic, Inc. (\"Soma Logic\") (the \"Merger\"), each option to purchase SomaLogic common stock (a \"SomaLogic Option\"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the \"Effective Time\"), was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 (the \"Exchange Ratio\") rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying the option vest on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is fully vested, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":205794,"derivative":{"exercise_price":2.47,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":205794},"source":{"system":"sec-edgar","filing":"0001104659-24-002652","document":"tm242400-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002652/tm242400-5_4seq1.xml","form_type":"4"}},{"id":1683000,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T23:05:19.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":79412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vest in four equal annual installments beginning January 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":79412,"source":{"system":"sec-edgar","filing":"0001104659-24-002652","document":"tm242400-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924002652/tm242400-5_4seq1.xml","form_type":"4"}},{"id":1858369,"issuer":{"id":95310,"kind":"organization","name":"SomaLogic, Inc.","symbol":"SLGC"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-13T01:12:25.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":185400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vest monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date."}],"balance_after":185400,"derivative":{"exercise_price":2.74,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":185400},"source":{"system":"sec-edgar","filing":"0001209191-23-036534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574633/000120919123036534/doc4.xml","form_type":"4"}},{"id":2684036,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T16:03:08.000Z","date":"2001-06-02","kind":"sale","acquired":false,"shares":17000,"price":108.11,"value":1837870.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5292,"source":{"system":"sec-edgar","filing":"0001209191-21-037602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919121037602/doc4.xml","form_type":"4"}},{"id":3000884,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-23T16:44:23.000Z","date":"2020-10-22","kind":"grant","acquired":true,"shares":420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":22292,"source":{"system":"sec-edgar","filing":"0001209191-20-055687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120055687/doc4.xml","form_type":"4"}},{"id":3069959,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-04T17:21:28.000Z","date":"2020-07-31","kind":"exercise","acquired":false,"shares":15620,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.24,"exercise_date":"2014-04-29","expiration_date":"2023-04-29","underlying":"Common Stock","underlying_shares":15620},"source":{"system":"sec-edgar","filing":"0001209191-20-044761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120044761/doc4.xml","form_type":"4"}},{"id":3069958,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-04T17:21:28.000Z","date":"2020-07-31","kind":"sale","acquired":false,"shares":30620,"price":94,"value":2878280.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":21872,"source":{"system":"sec-edgar","filing":"0001209191-20-044761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120044761/doc4.xml","form_type":"4"}},{"id":3069957,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-04T17:21:28.000Z","date":"2020-07-31","kind":"exercise","acquired":true,"shares":15620,"price":9.24,"value":144328.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon exercise of a stock option award."}],"balance_after":52492,"source":{"system":"sec-edgar","filing":"0001209191-20-044761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120044761/doc4.xml","form_type":"4"}},{"id":3076353,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-24T16:28:42.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":2691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":36872,"source":{"system":"sec-edgar","filing":"0001209191-20-043596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919120043596/doc4.xml","form_type":"4"}},{"id":3449613,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T16:20:53.000Z","date":"2019-07-31","kind":"sale","acquired":false,"shares":457,"price":120.19,"value":54926.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.13 to $120.24, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":34181,"source":{"system":"sec-edgar","filing":"0001209191-19-044243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119044243/doc4.xml","form_type":"4"}},{"id":3449612,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T16:20:53.000Z","date":"2019-07-31","kind":"sale","acquired":false,"shares":2770,"price":119.3,"value":330461.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.85 to $119.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":34638,"source":{"system":"sec-edgar","filing":"0001209191-19-044243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119044243/doc4.xml","form_type":"4"}},{"id":3449611,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T16:20:53.000Z","date":"2019-07-31","kind":"sale","acquired":false,"shares":2436,"price":118.21,"value":287959.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.81 to $118.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":37408,"source":{"system":"sec-edgar","filing":"0001209191-19-044243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119044243/doc4.xml","form_type":"4"}},{"id":3449610,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T16:20:53.000Z","date":"2019-07-31","kind":"sale","acquired":false,"shares":1200,"price":117.33,"value":140796.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.72 to $117.72, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":39844,"source":{"system":"sec-edgar","filing":"0001209191-19-044243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119044243/doc4.xml","form_type":"4"}},{"id":3449609,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T16:20:53.000Z","date":"2019-07-31","kind":"sale","acquired":false,"shares":1800,"price":115.89,"value":208602.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.52 to $116.24, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":41044,"source":{"system":"sec-edgar","filing":"0001209191-19-044243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119044243/doc4.xml","form_type":"4"}},{"id":3449608,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T16:20:53.000Z","date":"2019-07-31","kind":"sale","acquired":false,"shares":1337,"price":114.99,"value":153741.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.51 to $115.34, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":42844,"source":{"system":"sec-edgar","filing":"0001209191-19-044243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119044243/doc4.xml","form_type":"4"}},{"id":3455316,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-26T16:57:57.000Z","date":"2019-07-25","kind":"grant","acquired":true,"shares":2698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":44181,"source":{"system":"sec-edgar","filing":"0001209191-19-043373","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119043373/doc4.xml","form_type":"4"}},{"id":3623600,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-01T17:19:27.000Z","date":"2019-02-28","kind":"sale","acquired":false,"shares":7500,"price":96,"value":720000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":41483,"source":{"system":"sec-edgar","filing":"0001209191-19-015109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919119015109/doc4.xml","form_type":"4"}},{"id":3857001,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-01T17:04:24.000Z","date":"2018-07-30","kind":"sale","acquired":false,"shares":3427,"price":58.86,"value":201713.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person to cover tax liabilities arising out of the vesting of shares of restricted stock."}],"balance_after":48983,"source":{"system":"sec-edgar","filing":"0001209191-18-044761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919118044761/doc4.xml","form_type":"4"}},{"id":3859178,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2018-07-30T19:32:38.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents deferred stock unit award issued pursuant to the Company's non-employee director compensation policy. Each deferred stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These deferred stock units vest in full on the first anniversary of the grant date or, if earlier, the date of the next annual meeting of the Company's stockholders. Deferred stock units that become earned and vested are payable upon separation of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These deferred stock units vest in full on the first anniversary of the grant date or, if earlier, the date of the next annual meeting of the Company's stockholders. Deferred stock units that become earned and vested are payable upon separation of service."}],"balance_after":3230,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001209191-18-044479","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919118044479/doc4.xml","form_type":"4"}},{"id":3964852,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-12T16:10:54.000Z","date":"2018-04-10","kind":"sale","acquired":false,"shares":200,"price":40.838,"value":8167.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person to cover tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $40.985, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":52410,"source":{"system":"sec-edgar","filing":"0001209191-18-024727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919118024727/doc4.xml","form_type":"4"}},{"id":3964851,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-12T16:10:54.000Z","date":"2018-04-10","kind":"sale","acquired":false,"shares":8248,"price":39.702,"value":327462.096,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person to cover tax liabilities arising out of the vesting of shares of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.34 to $40.23, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":52610,"source":{"system":"sec-edgar","filing":"0001209191-18-024727","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919118024727/doc4.xml","form_type":"4"}},{"id":4229727,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-18T16:07:35.000Z","date":"2017-08-17","kind":"purchase","acquired":true,"shares":2500,"price":37.71,"value":94275.0,"ownership":{"direct":true},"balance_after":60858,"source":{"system":"sec-edgar","filing":"0001209191-17-049599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919117049599/doc4.xml","form_type":"4"}},{"id":4248569,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36081,"kind":"person","name":"Carey Thomas D.","position":1,"cik":"0001574633","reported_name":"Carey Thomas D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-31T17:18:22.000Z","date":"2017-07-27","kind":"grant","acquired":true,"shares":6723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issuesd pursuant to the Company's non-employee director compensation policy."}],"balance_after":58358,"source":{"system":"sec-edgar","filing":"0001209191-17-046726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000120919117046726/doc4.xml","form_type":"4"}}]}